Cannbit Pharmaceuticals Ltd operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cannbit Pharmaceuticals Ltd with three other pharmaceutical manufacturers in Middle East: Solegreen Ltd (2013 sales of 3.77 million Israel Shekels [US$1.04 million] ), Rosetta Genomics Ltd. (USA) (1.46 million Israel Shekels [US$400,975.09 ] ), and Sabaa International Co For Pharmaceutical And Chemical Industries which is based in Egypt (15.32 million Egyptian Pounds [US$870,701.44 ] ).

Sales Analysis. Sales fell dramatically in 2013: During the year ended December of 2013, sales at Cannbit Pharmaceuticals Ltd were 2.60 million Israel Shekels (US$713.77 thousand). This is a sharp decrease of 72.2% versus 2012, when the company's sales were 9.35 million Israel Shekels.